Showing 1,241 - 1,260 results of 122,662 for search '(( 5 ((((nm decrease) OR (mean decrease))) OR (a decrease)) ) OR ( 2 e decrease ))', query time: 1.59s Refine Results
  1. 1241
  2. 1242
  3. 1243

    VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

    Published 2018
    “…<b>(D)</b> HR [hazard ratio] of 1.72, p<1x10<sup>-16</sup>). <b>(E)</b> Similar analysis of 2,061 patients with ER<sup>+</sup> breast cancer (HR 1.48, p = 5.5x10<sup>-6</sup>). …”
  4. 1244
  5. 1245
  6. 1246

    Ibuprofen and diclofenac decrease proliferation. by Verena Leidgens (815986)

    Published 2015
    “…<p>Proliferation was analyzed using crystal violet staining and results were verified via the CyQuant Direct Cell Proliferation assay in HTZ-349. (A) Starting at 72 h, all ibuprofen concentrations (0.5, 1, 2 mM) resulted in significant reduction of HTZ-349 proliferation (compared to non-treated Ctrl, 95% CI, p < 0.05). 2 mM ibuprofen caused significant proliferation inhibition at 24 h (0.01 > p ≤ 0.001) and 48 h (p < 0.0001). …”
  7. 1247
  8. 1248
  9. 1249

    WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

    Published 2024
    “…</b> RT-qPCR of WT1, p<0.05(*), vFLIP(ns), LANA, p<0.0001(****), K8.1, p<0.0001(****), and BCL2 p<0.05(*) in the setting of WT1 knockdown in ISLK BAC-16 with WT1 siRNA in comparison to a control siRNA using two-sided, unpaired student’s t-tests. …”
  10. 1250
  11. 1251

    Decreased 11ß-HSD1 protein level by IGF-I overexpression <i>in vivo</i> and a direct treatment with IGF-I. by Subrata Chowdhury (787208)

    Published 2015
    “…<p><b>A</b>. IGF-I overexpression decreased the levels of 11ß-HSD1 in pancreatic islets, liver and visceral fat, shown in Western blots. …”
  12. 1252

    Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  13. 1253
  14. 1254
  15. 1255

    Parvalbumin-positive interneurons (PV-INs) in perilesional tissue respond to optogenetic stimulation and are involved in voluntary movement, but show a decreased firing rate. by Livia Vignozzi (22430567)

    Published 2025
    “…Data are shown as mean ± SEM. Created in BioRender. Vignozzi, L. (2025) <a href="https://BioRender.com/md8zh2c" target="_blank">https://BioRender.com/md8zh2c</a>. …”
  16. 1256

    A Yoga Strengthening Program Designed to Minimize the Knee Adduction Moment for Women with Knee Osteoarthritis: A Proof-Of-Principle Cohort Study by Elora C. Brenneman (795723)

    Published 2015
    “…A secondary objective was to determine whether the program could improve mobility and fitness, and decrease peak KAM during gait. …”
  17. 1257

    CII, inhibitor of SphK, decreases both the migration of HPAECs in a scratch assay <i>in vitro</i> and the content of S1P in HPAECs. by Evgeny V. Berdyshev (307465)

    Published 2013
    “…<p>HPAECs grown to ∼95% confluence in 35 mm dishes were starved for 3 h in 0.1% FBS in EBM-2 without growth factors and treated with 10 µM of CII. …”
  18. 1258
  19. 1259
  20. 1260